Application of biological growth risk models to the management of built heritage

La qualità degli spazi interni è fortemente legata alle condizioni igrotermiche che influenzano il comfort degli utenti e i rischi di conservazione del patrimonio edilizio. Inoltre, una gestione incurante di spazi espositivi con numerosi accessi può causare carichi eccessivi di umidità, e conseguenti fenomeni di degrado. In questo lavoro, è stata considerata una sala espositiva rappresentativa del patrimonio costruito. Il rischio di proliferazione biologica è indagato nelle condizioni climatiche di Milano e Barcellona, con diversi ratei di ventilazione e numero di visitatori. I risultati delineano la necessità di politiche informate da analisi avanzate per prevenire il rischio igrotermico, in assenza di impianti, che non è sempre possibile integrare nel patrimonio edilizio storico.The quality of the interior spaces is strongly related to the hygro-thermal conditions which affect the users’ comfort, and may yield to preservation risk for the built heritage. Moreover, careless management of exposition spaces with excessive occupancy may result in moisture loads that promote degradation. In this paper, as a case study, an exposition hall representative of the built heritage is considered. The microbiological growth risk is investigated at two different climate conditions, namely Milan and Barcelona, considering varying ventilation rates and number of visitors. The results outline the need of policies informed by advanced analyses to prevent hygro-thermal risk in the absence of dedicated building services, that cannot always be integrated in built heritage

Real-time prediction of breast lesions displacement during Ultrasound scanning using a position-based dynamics approach.

Although ultrasound (US) images represent the most popular modality for guiding breast biopsy, they are sometimes unable to render malignant regions, thus preventing accurate lesion localization which is essential for a successful procedure. Biomechanical models can support the localization of suspicious areas identified on a pre-operative image during US scanning since they are able to account for anatomical deformations resulting from US probe pressure. We propose a deformation model which relies on position-based dynamics (PBD) approach to predict the displacement of internal targets induced by probe interaction during US acquisition. The PBD implementation available in NVIDIA FleX is exploited to create an anatomical model capable of deforming in real-time. In order to account for each patient\u2019s specificities, model parameters are selected as those minimizing the localization error of a US-visible landmark of the anatomy of interest (in our case, a realistic breast phantom). The updated model is used to estimate the displacement of other internal lesions due to probe-tissue interaction. The proposed approach is compared to a finite element model (FEM), generally used in breast biomechanics, and a rigid one. Localization error obtained when applying the PBD model remains below 11 mm for all the tumors even for input displacements in the order of 30 mm. The proposed method obtains results aligned with FE models with faster computational performance, suitable for real-time applications. In addition, it outperforms rigid model used to track lesion position in US-guided breast biopsies, at least halving the localization error for all the displacement ranges considered. Position-based dynamics approach has proved to be successful in modeling breast tissue deformations during US acquisition. Its stability, accuracy and real-time performance make such model suitable for tracking lesions displacement during US-guided breast biopsy

A position-based framework for the prediction of probe-induced lesion displacement in Ultrasound-guided breast biopsy

Although ultrasound (US) images represent the most popular modality for guiding breast biopsy, they are sometimes unable to render malignant regions, thus preventing accurate lesion localization which is essential for a successful procedure. Biomechanical models can support the localization of suspicious areas identified on a pre-operative image during US scanning since they are able to account for anatomical deformations resulting from US probe pressure. We propose a deformation model which relies on position-based dynamics (PBD) approach to predict the displacement of internal targets induced by probe interaction during US acquisition. The PBD implementation available in NVIDIA FleX is exploited to create an anatomical model capable of deforming online. Simulation parameters are initialized on a calibration phantom under different levels of probe-induced deformations, then they are fine-tuned by minimizing the localization error of a US-visible landmark of a realistic breast phantom. The updated model is used to estimate the displacement of other internal lesions due to probe-tissue interaction. The localization error obtained when applying the PBD model remains below 11 mm for all the tumors even for input displacements in the order of 30 mm. This approach outperforms rigid model used to track lesion position in US-guided breast biopsies, at least halving the localization error for all the displacement ranges considered. Position-based dynamics approach has proved to be successful in modeling breast tissue deformations during US acquisition. Its stability, accuracy and real-time performance make such model suitable for tracking lesions displacement during US-guided breast biopsy

Dynamic facial expressions of emotions are discriminated at birth

The ability to discriminate between different facial expressions is fundamental since the first stages of postnatal life. The aim of this study is to investigate whether 2-days-old newborns are capable to discriminate facial expressions of emotions as they naturally take place in everyday interactions, that is in motion. When two dynamic displays depicting a happy and a disgusted facial expression were simultaneously presented (i.e., visual preference paradigm), newborns did not manifest any visual preference (Experiment 1). Nonetheless, after being habituated to a happy or disgusted dynamic emotional expression (i.e., habituation paradigm), newborns successfully discriminated between the two (Experiment 2). These results indicate that at birth newborns are sensitive to dynamic faces expressing emotions

Heregulin β1 induces the down regulation and the ubiquitin-proteasome degradation pathway of p185HER2 oncoprotein

AbstractAnalysis of the fate of the p185HER2 oncoprotein following activation by heregulin β1 revealed the induction of the tyrosine-phosphorylation, down-modulation, and polyubiquitination of p185HER2. Receptor ubiquitination was suppressed in cells treated with heregulin β1 in the presence of sodium azide, an inhibitor of ATP-dependent reactions, or genistein, a tyrosine kinase protein inhibitor, indicating the requirement for kinase activity and ATP in p185HER2 polyubiquitination. Ubiquitinated p185HER2 was degradated by the 26S proteasome proteolytic pathway. Kinetics and inhibition experiments indicated that endocytosis of the receptor occurs downstream of the initiation of the degradation process

Efficacy of atropine 0.01% for the treatment of childhood myopia in European patients

Purpose: To evaluate the efficacy and safety of atropine 0.01% in slowing myopia progression in European paediatric patients. Methods: Retrospective, medical records review study. Medical charts of paediatric patients with a myopia progression > 0.5 D/year treated with atropine 0.01% for at least 1 year were included. Patients receive a complete ophthalmic examination before and 12 months after initiation of atropine treatment. A group of myopic untreated children serves as a control group. The rate of myopia progression at baseline and 12 months after treatment with atropine was evaluated. The rate of myopia progression in treated and untreated patients was also compared. Adverse events were recorded. Results: Medical records of 52 treated and 50 control subjects were analysed. In the atropine group, the mean rate of myopia progression after 12 months of treatment ( 120.54 \ub1 0.61 D) was significantly slower compared with the baseline progression ( 121.20 \ub1 0.64 D; p < 0.0001) and to the progression in the control group ( 121.09 \ub1 0.64; p < 0.0001). The responders patients were 41/52 (79%), whereas 11/52 patients (21%) showed a progression > 0.50 D despite treatment. The only adverse event was temporary photophobia in five patients (9.6%), severe adverse events were not reported, and none of the patients discontinued the treatment. Conclusion: Low-dose atropine significantly slowed the rate of myopia progression in European paediatric patients with a favourable safety profile